Want to see IL:ISCN full AI Analyst Report?
Top Page
Israel Canada
(TASE:ISCN)
Select Model
Select Model
Rating:39Underperform
Price Target:
1,397.00
▼(-17.14% Downside)
Action:Downgraded
Date:08/06/26
The score is driven primarily by weak financial quality—persistent negative operating/free cash flow and high leverage—alongside unstable profitability. Technicals add further pressure with a clear downtrend (below key moving averages, negative MACD), while valuation is the weakest factor due to an extremely elevated P/E and only a modest dividend yield.
Positive Factors
Revenue recovery and trend
A material rebound into 2025 and stable TTM revenue indicates underlying project demand and execution capacity. Durable revenue recovery supports continued project pipelines, improves negotiating leverage with contractors and buyers, and reduces reliance on one-off asset disposals to fund operations.
Negative Factors
High leverage / debt intensity
Sustained debt-to-equity near 2.3–2.9x materially raises refinancing and interest-rate vulnerability. High leverage reduces financial flexibility, elevates default or forced-asset-sale risk in downturns, and increases financing costs that erode long-term development margins.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue recovery and trend
A material rebound into 2025 and stable TTM revenue indicates underlying project demand and execution capacity. Durable revenue recovery supports continued project pipelines, improves negotiating leverage with contractors and buyers, and reduces reliance on one-off asset disposals to fund operations.
Read all positive factors
Israel Canada (ISCN) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪5.04B
Dividend Yield0.48%
Average Volume (3M)774.36K
Price to Earnings (P/E)5684.6
Beta (1Y)1.77
Revenue Growth66.09%
EPS Growth-100.79%
CountryIL
Employees110
SectorGeneral
Sector StrengthN/A
IndustryReal Estate - Development
Share Statistics
EPS (TTM)<0.01
Shares Outstanding341,097,260
10 Day Avg. Volume1,105,504
30 Day Avg. Volume774,364
Financial Highlights & Ratios
PEG Ratio-2.19
Price to Book (P/B)2.03
Price to Sales (P/S)6.21
P/FCF Ratio-7.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Israel Canada Business Overview & Revenue Model
Company Description
Israel Canada (T.R) Ltd. engages in the construction of real estate projects and management of acquisition groups. It operates through the following areas: Entrepreneurial Real Estate in Israel and Poland; Entrepreneurial Real Estate in Russia; Es...
How the Company Makes Money
ISCN primarily makes money through (1) real estate development profits and sales: generating revenue when residential units or commercial properties in development projects are sold to end buyers (with profits driven by the spread between total pr...
Israel Canada Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
33
Negative
Cash Flow
24
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 878.88M | 877.01M | 501.62M | 547.57M | 1.52B | 350.93M |
| Gross Profit | 82.25M | 114.37M | 140.13M | 175.70M | 526.39M | 151.42M |
| EBITDA | 295.85M | 288.44M | 317.75M | 100.44M | 536.67M | 809.32M |
| Net Income | -2.59M | 28.83M | 206.37M | -55.74M | 268.76M | 571.01M |
Balance Sheet | ||||||
| Total Assets | 13.21B | 12.64B | 10.96B | 8.58B | 8.71B | 8.17B |
| Cash, Cash Equivalents and Short-Term Investments | 571.32M | 309.88M | 539.47M | 295.28M | 944.74M | 776.64M |
| Total Debt | 8.01B | 7.64B | 6.67B | 5.18B | 5.33B | 5.02B |
| Total Liabilities | 9.29B | 8.90B | 7.49B | 5.53B | 5.75B | 5.71B |
| Stockholders Equity | 2.82B | 2.69B | 2.49B | 2.23B | 2.14B | 1.75B |
Cash Flow | ||||||
| Free Cash Flow | -574.87M | -727.77M | -148.38M | -240.52M | 217.23M | -1.92B |
| Operating Cash Flow | -495.52M | -660.95M | -88.42M | -169.15M | 435.52M | -1.82B |
| Investing Cash Flow | -214.03M | 76.02M | -1.04B | 278.48M | -681.21M | -1.04B |
| Financing Cash Flow | 737.97M | 321.08M | 1.34B | -113.48M | 313.51M | 2.84B |
Israel Canada Technical Analysis
Negative
1686.00
Price Trends
1774.84
Negative
1908.26
Negative
1834.14
Negative
Market Momentum
-86.83
Positive
34.99
Neutral
12.87
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:ISCN, the sentiment is Negative. The current price of 1686 is above the 20-day moving average (MA) of 1642.80, below the 50-day MA of 1774.84, and below the 200-day MA of 1834.14, indicating a bearish trend. The MACD of -86.83 indicates Positive momentum. The RSI at 34.99 is Neutral, neither overbought nor oversold. The STOCH value of 12.87 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:ISCN.
Israel Canada Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ₪7.88B | 12.07 | ― | 3.39% | 20.47% | 16.75% | |
56 Neutral | ₪1.73B | 83.22 | ― | 3.36% | 9.78% | -81.33% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | ₪1.61B | 6.59 | ― | 3.85% | 10.79% | 140.47% | |
51 Neutral | ₪6.75B | 29.22 | ― | 1.39% | 2.73% | 25.96% | |
50 Neutral | ₪2.79B | 12.48 | ― | 1.21% | 36.52% | -0.11% | |
39 Underperform | ₪5.04B | 5,684.62 | ― | 0.43% | 66.09% | -100.79% |
* General Sector Average
IL:ISCN
Israel Canada
1,520.00
-43.72
-2.80%
IL:GVYM
Gav Yam
3,607.00
47.68
1.34%
IL:ILDC
Land Dev
3,917.00
472.76
13.73%
IL:ASHG
Ashtrom Group
6,060.00
-458.42
-7.03%
IL:PRSK
Prashkovsky
13,360.00
1,383.52
11.55%
IL:CRSR
Carasso Real Estate Ltd.
2,984.00
-167.00
-5.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.